Concert Pharmaceuticals to Report Full Year 2020 Results on February 25, 2021

Rhea-AI Summary

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) will release its financial results for the year ending December 31, 2020, on February 25, 2021, before the U.S. markets open. The company will hold a conference call at 8:30 a.m. ET to discuss the results and provide a business update. Interested participants can join via U.S. dial-in at (855) 354-1855 or international at (484) 365-2865. A live webcast will be available on the company's website and a replay will be accessible for three months.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2020, on Thursday, February 25, 2021, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss 2020 financial results and provide a business update. Individuals interested in participating in the call should dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865 (International).

A live webcast of the conference call may be accessed in the Investors section of the Company’s website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Concert’s website for three months.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform^® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005046/en/

FAQ

When will Concert Pharmaceuticals (CNCE) report its 2020 financial results?

Concert Pharmaceuticals will report its financial results for 2020 on February 25, 2021.

What time is the conference call for Concert Pharmaceuticals on February 25, 2021?

The conference call will take place at 8:30 a.m. ET.

How can I access the webcast for Concert Pharmaceuticals' financial results?

The webcast can be accessed through the Investors section of Concert Pharmaceuticals' website.

Will there be a replay of the conference call from Concert Pharmaceuticals?

Yes, a replay of the webcast will be available on the company's website for three months.

What is the main focus of Concert Pharmaceuticals' research?

Concert Pharmaceuticals is developing small molecule drugs, including a lead candidate for the treatment of alopecia areata.